Shuxiong Xu

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesSocio-economic developmentSurface water quality processes and contaminated sediment assessmentCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2026
Downregulation of SELENOS Suppresses the Progression of Renal Cell Carcinoma by Activating Ferroptosis.

|May 06, 2025
Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis.

Yuangao Xu, Jieyu Xiong, Yikun Wu

|Jan 04, 2025
Selenium: 48-year journey of global clinical trials.

Yikun Wu, Jun Pei, Yuangao Xu

|May 27, 2024
miR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274.

GuangYi Hong, YiKun Wu, ShiYu Huang

|May 13, 2022
Selenoprotein Gene mRNA Expression Evaluation During Renal Ischemia-Reperfusion Injury in Rats and Ebselen Intervention Effects.

Yikun Wu, Hua Shi, Yuangao Xu

|Mar 26, 2022
Ebselen ameliorates renal ischemia-reperfusion injury via enhancing autophagy in rats.

Yikun Wu, Hua Shi, Yuangao Xu

Pageof 1

Frequent Collaborators

2 joint publications

Hua Shi

1 joint publications

Yuangao Xu

1 joint publications

Jieyu Xiong

1 joint publications

Yikun Wu